TikTok CEO Predicts AI Scientific Breakthroughs Within Three Years
Shou Zi Chew expects AI breakthroughs in science within two to three years. ByteDance’s Protenix research shows progress, while verification and agent safety remain key.
#Biotechnology
Explore AIstify's latest reporting, research, and expert analysis tagged with "biotechnology", collected in one continuously updated archive.
Related Posts
Claude Agents Discover a Novel Enzyme System With CRISPR Like Features
Anthropic says Claude agents in its life sciences lab discovered a novel enzyme system with CRISPR like features in bacteriophage DNA, reviewed favorably by CRISPR pioneer Feng Zhang.
Anthropic Reports Claude Misuse Involving Dangerous Biological Research
Anthropic says it disrupted high-concern biological uses of Claude, including requests linked to dangerous pathogens, while cautioning that harmful intent was not established.
Lady Gaga’s Fiancé Trains AI on Living Human Skin Tissue
By
Laura Bennett
• 4 mins read
Michael Polansky’s biotech startup Outer Biosciences keeps donated human skin alive for weeks and uses it to train an AI that predicts promising new skincare ingredients.
Recursion Pharmaceuticals
By
AIstify Team
• 4 mins read
Recursion Pharmaceuticals is a biotechnology company known for industrialized biology, computational drug discovery, and clinical-stage therapeutic programs.
Insilico Medicine
By
AIstify Team
• 4 mins read
Insilico Medicine is a biotechnology company known for AI-enabled drug discovery platforms, generative chemistry, and therapeutic development.
Google DeepMind Unveils AlphaGenome DNA Prediction Model
By
Samantha Reed
• 4 mins read
Google DeepMind has introduced AlphaGenome, a new AI model designed to analyze long DNA sequences and predict how genetic variations may influence disease development.
Health & Biotechnology
By
AIstify Team
• 1 min read
AI coverage of health and biotechnology, tracking deployments, deals, and policy shaping care delivery, drug discovery, and biomedical research.
AstraZeneca Inks $555M AI-CRISPR Deal with Algen to Target Immunology
By
Samantha Reed
• 3 mins read
AstraZeneca has signed a $555 million milestone-based partnership with Algen Biotechnologies to deploy AI and CRISPR gene-editing together for immunology drug discovery.